267 related articles for article (PubMed ID: 28776444)
1. Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions.
Adiwidjaja J; McLachlan AJ; Boddy AV
Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):953-972. PubMed ID: 28776444
[TBL] [Abstract][Full Text] [Related]
2. Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part I: Curcumin.
Di Martino RM; Luppi B; Bisi A; Gobbi S; Rampa A; Abruzzo A; Belluti F
Expert Opin Ther Pat; 2017 May; 27(5):579-590. PubMed ID: 28024125
[TBL] [Abstract][Full Text] [Related]
3. Systemic delivery of curcumin: 21st century solutions for an ancient conundrum.
Bisht S; Maitra A
Curr Drug Discov Technol; 2009 Sep; 6(3):192-9. PubMed ID: 19496751
[TBL] [Abstract][Full Text] [Related]
4. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients.
Kanai M; Otsuka Y; Otsuka K; Sato M; Nishimura T; Mori Y; Kawaguchi M; Hatano E; Kodama Y; Matsumoto S; Murakami Y; Imaizumi A; Chiba T; Nishihira J; Shibata H
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1521-30. PubMed ID: 23543271
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
7. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers.
Jamwal R
J Integr Med; 2018 Nov; 16(6):367-374. PubMed ID: 30006023
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of curcumin.
Sharma RA; Steward WP; Gescher AJ
Adv Exp Med Biol; 2007; 595():453-70. PubMed ID: 17569224
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies with curcumin.
Hsu CH; Cheng AL
Adv Exp Med Biol; 2007; 595():471-80. PubMed ID: 17569225
[TBL] [Abstract][Full Text] [Related]
10. Curcumin: a boon to colonic diseases.
Sareen R; Jain N; Pandit V
Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
[TBL] [Abstract][Full Text] [Related]
11. Recent progress on curcumin-based therapeutics: a patent review (2012-2016). Part II: curcumin derivatives in cancer and neurodegeneration.
Di Martino RMC; Bisi A; Rampa A; Gobbi S; Belluti F
Expert Opin Ther Pat; 2017 Aug; 27(8):953-965. PubMed ID: 28597702
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in curcumin nanoformulation for cancer therapy.
Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
[TBL] [Abstract][Full Text] [Related]
13. Curcumin uptake and metabolism.
Metzler M; Pfeiffer E; Schulz SI; Dempe JS
Biofactors; 2013; 39(1):14-20. PubMed ID: 22996406
[TBL] [Abstract][Full Text] [Related]
14. Development and pharmacokinetic evaluation of a curcumin co-solvent formulation.
John MK; Xie H; Bell EC; Liang D
Anticancer Res; 2013 Oct; 33(10):4285-91. PubMed ID: 24122994
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R
Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer.
Heger M; van Golen RF; Broekgaarden M; Michel MC
Pharmacol Rev; 2014; 66(1):222-307. PubMed ID: 24368738
[TBL] [Abstract][Full Text] [Related]
17. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
Shehzad A; Wahid F; Lee YS
Arch Pharm (Weinheim); 2010 Sep; 343(9):489-99. PubMed ID: 20726007
[TBL] [Abstract][Full Text] [Related]
18. Evaluation in vitro and in vivo of curcumin-loaded mPEG-PLA/TPGS mixed micelles for oral administration.
Duan Y; Zhang B; Chu L; Tong HH; Liu W; Zhai G
Colloids Surf B Biointerfaces; 2016 May; 141():345-354. PubMed ID: 26874910
[TBL] [Abstract][Full Text] [Related]
19. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin.
Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J
Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002
[TBL] [Abstract][Full Text] [Related]
20. Boosting the oral bioavailability of anticancer drugs through intentional drug-drug interactions.
Eisenmann ED; Talebi Z; Sparreboom A; Baker SD
Basic Clin Pharmacol Toxicol; 2022 Jan; 130 Suppl 1(Suppl 1):23-35. PubMed ID: 34117715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
